- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 4.2 Specimen Common Stock Certificate of the Registrant
- 10.16 Warrant
- 10.49 Master Services Agreement - Aai Developmental Services Inc.
- 10.50 First Amendment to Master Services Agreement - Aaipharma Inc.
- 10.51 Second Amendment to Master Services Agreement - Aaipharma Inc.
- 10.52 Third Amendment to Master Services Agreement - Aaipharma Services Corp
- 10.53 Master Services Agreement - Albany Molecular Research, Inc.
- 10.54 Master Services Agreement - Icon Clinical Research Limited
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A) or 15D-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A) or 15D-14(A)
- 32.1 Certification of CEO & CFO Pursuant to 13A-14(B) or 15D-14(B)
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-164025, 333-166366 and 333-168191) and related Prospectuses, and the Registration Statements on Form S-8 (Nos. 333-128647, 333-132679, 333-138758, 333-145404, 333-150834 and 333-160528) pertaining to the 1998 Stock Plan, 2001 Stock Plan, 2005 Equity Incentive Award Plan, Amended and Restated 2006 Employment Commencement Incentive Plan and Employee Stock Purchase Plan of Sunesis Pharmaceuticals, Inc., of our report dated March 29, 2011, with respect to the consolidated financial statements of Sunesis Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
Palo Alto, California
March 29, 2011